Cell and Gene Therapy Catapult Manufacturing Centre

The Cell and Gene Therapy Catapult sought to develop a pioneering manufacturing centre to support the scale-up of advanced therapies, bridging the gap between research and commercialisation. The project required the delivery of a highly specialised GMP-compliant environment with complex cleanroom specifications and process infrastructure. The challenge was to create a flexible, future-proof facility that met stringent technical and regulatory demands while ensuring value for public and private investment.

G&T provided Cost Management services, working closely with the client, design team and specialist contractors to maintain financial control throughout the project lifecycle. Our team helped manage cost risk across complex technical packages, supported value engineering, and ensured budget, scope and programme alignment. Our commercial leadership was key to securing cost certainty on a fast-paced, high-specification project within a rapidly evolving life sciences sector.

The completed Manufacturing Innovation Centre provides world-class facilities to support the development and production of cell and gene therapies at scale. It has become a critical asset within the UK’s life sciences landscape, enabling innovation, investment and accelerated delivery of cutting-edge treatments. Our commercial insight helped unlock a complex, fast-paced scheme—delivering a facility that enables innovation to move from concept to clinic more efficiently.